Delivery Order SPE2DB22D3009-SPE2DB25FBE73
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,582.67 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order is set to be completed by August 26, 2025, just one day after the award date of August 25, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,435.33 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive set-aside procurement executed through AmerisourceBergen's existing contract vehicle with the DLA. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,920.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price delivery order with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $39,958.00 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitive, non-set-aside delivery order is set to be completed by September 9, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency (DLA) awarded a $3,024.00 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no...
- The Defense Logistics Agency awarded a $13,817.08 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed price contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $12,202.67 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on July 24, 2025, with a completion date of July 25, 2025, and represents a non-set-aside competitive procurement. The award was issued from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a $16,409.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The award, issued on July 22, 2025, is a non-set-aside competitive procurement with an ultimate completion date of July 23, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,665.23 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. This non-competitive delivery order represents a firm fixed price transaction with a completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,350.27 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 26, 2025. The award was processed on August 25, 2025, with performance taking place at AmerisourceBergen's corporate...